GlassScriptPhysician profile
Thomas Andrea
NPI 1669881041
$3,864.59
in general payments reported to CMS, 2019-2025
10 companies · $1,342 in 2025
The $1,342 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,522 · 2025: $1,342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,607 · Travel and Lodging: $825 · Consulting Fee: $695 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $400 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,606.70 |
| Travel and Lodging | $825.39 |
| Consulting Fee | $695.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $400.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $337.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,900.38 | 2024-2025 | Infuse, Xiidra, Miebo |
| Alcon Vision LLC | $485.10 | 2024-2025 | Air Optix, Tryptyr |
| Coopervision INC. | $366.70 | 2024-2025 | Clariti Contact Lens, Misight Contact Lens |
| Johnson & Johnson Vision Care, INC. | $346.71 | 2024-2025 | Acuvue |
| Glaukos Corporation | $255.30 | 2025 | Istent Infinite |
| Tarsus Pharmaceuticals, INC. | $215.76 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $157.64 | 2024-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $54.03 | 2024 | |
| Harrow Eye, LLC | $52.97 | 2024-2025 | Ilevro |
| Oyster Point Pharma, INC. | $30.00 | 2025 | Ryzumvi, Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Andrea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.